|
Assessment of effectiveness and safety of Dysport[R] for the treatment of hemifacial spasm.(CLINICAL TRIAL REVIEW)
From:
Journal of Drugs in Dermatology
| Date:
March 1, 2006
| COPYRIGHT 2006 Journal of Drugs in Dermatology, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.Copyright information
|
This study is currently recruiting patients. Verified and sponsored by Ipsen. To compare the effectiveness and safety of Dysport with the domestic Botulinum Toxin Type A (manufactured by Lanzhou Biologic Product Institute, P.R. China) for the treatment of ...
Related newspaper, magazine, and journal articles from HighBeam Research
|
Facial anatomy key to optimal use of botulinum toxin
Ophthalmology Times
; Functional, cosmetic aspects Approved, off-label applications continue to expand; experts offer practice pearls Plastics Pearls Botulinum toxin type A (Botox, Allergan) interferes with acetylcholine release from nerve terminals, causing temporary weakening of the muscles. The pioneering work on
|
|
Hemifacial spasm.(IMAGING CLINIC)(Case study)
Ear, Nose and Throat Journal
; [FIGURE OMITTED] Hemifacial spasm is a syndrome involving involuntary contraction of the muscles that are innervated by the ipsilateral facial nerve. It is important to distinguish this process from other types of facial spasm, such as psychogenic facial spasm, facial tic, facial myokymia,
|
|
Hemifacial spasm and other craniofacial movement disorders
Mayo Clinic Proceedings
; Craniofacial dyskinesias encompass a variety of abnormal spontaneous craniofacial movements that often appear similar in morphology but are, in fact, of varied cause and nature. Although hemifacial spasm and blepharospasm are the two most common abnormal craniofacial movements, the clinician should
|
|
|
Use of injectable agent requires knowledge of facial anatomy
Ophthalmology Times
; Facial rejuvenation Reviewed by Michael P. Grant, MD, PhD, FACS Baltimore-Botulinum toxin type A (Botox, Allergan) and hyaluronic acid (Restylane, Medicin Aesthetics Holdings Inc injectable fillers used in facial rejuvenation, are gaming increasing popularity with patients and surgeons. However,
|
|
Botulinum toxin type B starts strong as alternative
Dermatology Times
; Additional studies will determine if Myobloc continues to match success of botulinum toxin A Dallas - Botulinum toxin type B (Myobloc) is an alternative modality for improving the appearance of dynamic facial wrinkles, Leslie Baumann, M.D., said at the annual meeting of the American Society for
|
